Eiger BioPharmaceuticals, Inc. Quarterly Common Stock, Shares Authorized from Q4 2013 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Eiger BioPharmaceuticals, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2013 to Q4 2023.
  • Eiger BioPharmaceuticals, Inc. Common Stock, Shares Authorized for the quarter ending December 31, 2023 was 200M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 200M 0 0% Dec 31, 2023 10-K 2024-04-08
Q4 2022 200M 0 0% Dec 31, 2022 10-K 2024-04-08
Q4 2021 200M 0 0% Dec 31, 2021 10-K 2023-03-17
Q4 2020 200M 0 0% Dec 31, 2020 10-K 2022-03-10
Q4 2019 200M 0 0% Dec 31, 2019 10-K 2021-03-09
Q4 2018 200M 0 0% Dec 31, 2018 10-K 2020-03-13
Q4 2017 200M 0 0% Dec 31, 2017 10-K 2019-03-14
Q4 2016 200M +194M +3261% Dec 31, 2016 10-K 2018-03-09
Q1 2016 200M +197M +6010% Mar 31, 2016 10-Q 2016-05-16
Q4 2015 5.95M +3.82M +179% Dec 31, 2015 10-K 2017-03-23
Q3 2015 200M 0 0% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 200M 0 0% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 3.27M -197M -98.4% Mar 31, 2015 8-K/A 2016-06-17
Q4 2014 2.14M -178M -98.8% Dec 31, 2014 8-K/A 2016-06-17
Q3 2014 200M Sep 30, 2014 10-Q 2014-11-12
Q2 2014 200M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 200M Mar 31, 2014 10-Q 2014-05-13
Q4 2013 180M Dec 31, 2013 10-K 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.